PARIS, January 14, 2015 /PRNewswire/ --
Gecko Biomedical, a French medical device company developing 'bio-inspired' biodegradable surgical glues and patches for wound closure, announces today that Maria Pereira, PhD, Head of Adhesive Technologies, is featured by Forbes Magazine in its "30 under 30" list in Healthcare.
Forbes' fourth annual "30 Under 30" list features 600 young disruptors, innovators and entrepreneurs in 20 different fields. The complete list is available at http://www.forbes.com/30under30 .
"We are truly fortunate to have Maria as a core pillar of our incredibly talented team at Gecko Biomedical. This recognition by such a well-regarded international publication underlines Maria's exceptional talent, creativity and ambition to truly contribute to advancing science while improving patients' quality of life." said Christophe Bancel, Chief Executive Officer of Gecko Biomedical.
"This year's Forbes list is full of incredible minds and it is a great honor to be part of this talented generation that dreams high and works hard to make them a reality," said Maria Pereira. "This recognition would not be possible without the everyday inspiration and vision of mentors and colleagues that worktirelesslyto bring this technology closer to patients and improve their quality of life."
Notes to Editors
About Gecko Biomedical
Gecko Biomedical is a privately owned medical device company based in Paris, France that is dedicated to the rapid development and the commercialization of revolutionary biodegradable sealants and adhesives for wound closure in the field of surgery, with a key focus on minimally invasive surgery. Gecko Biomedical is developing products that are non-toxic, bind strongly to tissues and deliver 'on-demand' wound closure within the 'wet' and dynamic environments in the body. The Company's technology and products are based on world-class research and intellectual property from the laboratories of Robert Langer (MIT) and Jeff Karp (Brigham and Women's Hospital). Gecko was founded in 2013 and is backed by leading healthcare investors Omnes Capital, CM-CIC and CapDecisif Management.
SOURCE Gecko Biomedical